Efficacy of a Combination of b-Tricalcium Phosphate with Hyaluronic Acid in the Management of Intrabony Periodontal Defects: A Prospective Clinical Study

Selvaprakash, Kavitha; Ramachandran, Lakshmi; Parthasarathy, Harinath; Tadepalli, Anupama; Ponnaiyan, Deepa; Karthikeyan, Janani

doi:10.7860/jcdr/2021/51879.15791

Cited by 4 publications

(27 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[ 67 , 70 , 85 , 93 , 101 , 113 , 116 , 124 , 129 , 132 , 139 , 154 ] Some clinical trials do not specify further how this randomization is performed. [ 81 , 94 , 147 , 233 ] This approach might introduce further complexities when interpreting the results, and it has been found that most trials in periodontology could benefit from better methodological and reporting quality. [ 278 , 279 ] Furthermore, the studies should be designed to be long‐term, with the endpoint measurements being ideally taken at least 1 year postoperatively.…”

Section: Discussionmentioning

confidence: 99%

“…[ 231 ] Clinical trials support their efficacy in improving both clinical and radiographic outcomes. [ 158 , 227 , 232 , 233 , 234 ] Gupta et al. showed that Gengigel Prof syringes used within an OFD promote hard tissue metrics in treating class II furcation defects compared to OFD alone.…”

Section: Review Of Regenerative Products In Periodontal Regenerationmentioning

confidence: 99%

“…[ 232 ] Additionally, the clinical studies conducted by Selvaprakash and Bhowmik revealed that adding Gengigel Prof syringes to bone graft materials further enhances the clinical and radiographic outcomes, possibly because of better space‐maintaining properties. [ 158 , 233 ]…”

Section: Review Of Regenerative Products In Periodontal Regenerationmentioning

confidence: 99%

See 2 more Smart Citations

From Basic Science to Clinical Practice: A Review of Current Periodontal/Mucogingival Regenerative Biomaterials

De Lauretis,

Øvrebø,

Romandini

et al. 2024

Advanced Science

View full text Add to dashboard Cite

Periodontitis is a dysbiosis‐driven inflammatory disease affecting the tooth‐supporting tissues, characterized by their progressive resorption, which can ultimately lead to tooth loss. A step‐wise therapeutic approach is employed for periodontitis. After an initial behavioral and non‐surgical phase, intra‐bony or furcation defects may be amenable to regenerative procedures. This review discusses the regenerative technologies employed for periodontal regeneration, highlighting the current limitations and future research areas. The search, performed on the MEDLINE database, has identified the available biomaterials, including biologicals (autologous platelet concentrates, hydrogels), bone grafts (pure or putty), and membranes. Biologicals and bone grafts have been critically analyzed in terms of composition, mechanism of action, and clinical applications. Although a certain degree of periodontal regeneration is predictable in intra‐bony and class II furcation defects, complete defect closure is hardly achieved. Moreover, treating class III furcation defects remains challenging. The key properties required for functional regeneration are discussed, and none of the commercially available biomaterials possess all the ideal characteristics. Therefore, research is needed to promote the advancement of more effective and targeted regenerative therapies for periodontitis. Lastly, improving the design and reporting of clinical studies is suggested by strictly adhering to the Consolidated Standards of Reporting Trials (CONSORT) 2010 statement.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Review Of Regenerative Products In Periodontal Regenerationmentioning

confidence: 99%

See 1 more Smart Citation

From Basic Science to Clinical Practice: A Review of Current Periodontal/Mucogingival Regenerative Biomaterials

De Lauretis,

Øvrebø,

Romandini

et al. 2024

Advanced Science

View full text Add to dashboard Cite

show abstract

“…Two studies were excluded because they did not fulfill the eligibility criteria [12,33]. One of them was excluded because used a biologic hydrogel of recombinant human Fibroblast Growth Factor type 2 [12], the other because used a bioresorbable membrane (poly lactic acid-poly glycolic acid) [33] and one study was excluded from the meta-analysis because did no have data of common follow-up among studies [34]. Therefore, six articles were finally included in the SR, and five in the metaanalysis (Fig 1).…”

Section: Study Selectionmentioning

confidence: 99%

“…The studies included were six RCTs (three [34][35][36] with a parallel design and three [13,37,38] with a split-mouth design) conducted between 2012 and 2021. The main methodological characteristics of the studies included are presented in Table 1.…”

Section: Characteristics Of the Studies Includedmentioning

confidence: 99%

Eficacia clínica del ácido hialurónico en el tratamiento del defecto intraóseo periodontal: una revisión sistemática y meta-análisis

Ostos Aguilar

View full text Add to dashboard Cite

Objetivo: Esta revisión sistemática tuvo como objetivo evaluar los efectos del ácido hialurónico (AH) solo o en combinación con cualquier sustituto óseo para el tratamiento de los defectos intraóseos (DIO). Material y métodos: Se realizaron búsquedas en seis bases de datos hasta abril de 2022 para encontrar ensayos clínicos aleatorizados que compararán los efectos clínicos del desbridamiento con colgajo abierto (DCA)+AH frente al DCA solo (primer grupo) o DCA+AH + sustitutos óseos frente a DCA + sustitutos óseos (segundo grupo) en el tratamiento de los DIO con un seguimiento de al menos 3 meses. Se utilizaron modelos de efectos aleatorios de diferencias medias para determinar la ganancia del nivel de inserción clínica (NIC), la reducción de la profundidad de sondaje (PS) y el relleno óseo radiográfico (ROR). Resultados: De los 276 estudios identificados, 6 se incluyeron en la síntesis cualitativa y 5 en los metaanálisis. Los metaanálisis del primer grupo mostraron diferencias estadísticamente significativas en la ganancia del NIC (diferencia media [DM]: 1,00; intervalo de confianza [IC] del 95%: 0,65-1,35; n = 2) y la reducción de la PS (DM: 0,76; IC del 95%: 0,34-1,17; n = 2) a favor de AH+DCA a los 6 meses. Sin embargo, en el segundo grupo, los metaanálisis no demostraron un efecto adicional del AH en asociación con el sustituto óseo ni para la ganancia del NIC (DM: 0,57; IC del 95%: -0,30-1,43; n = 2) ni para la reducción de la PS (DM: 1,05; IC del 95%: -0,38-2,47; n = 2), pero sí mostraron diferencias significativas para el ROR (DM: 0,57; IC del 95%: 0,15-0,99; n = 2) a los 12 meses. Conclusiones: En comparación con el DCA solo, la aplicación local de AH en el tratamiento de los DIO proporcionó una ganancia significativa del NIC y una reducción de la PS a los 6 meses. Sin embargo, su combinación con sustitutos óseos no mostró diferencias estadísticamente significativas a los 12 meses. Importancia clínica: El uso de DCA+AH mejora el NIC y la PS en el tratamiento de los DIO en comparación con DCA sólo tras 6 meses de seguimiento. Estos resultados no se mantienen a los 12 meses.

show abstract

Clinical efficacy of hyaluronic acid in the treatment of periodontal intrabony defect: a systematic review and meta-analysis

et al. 2023

View full text Add to dashboard Cite

Efficacy of a Combination of b-Tricalcium Phosphate with Hyaluronic Acid in the Management of Intrabony Periodontal Defects: A Prospective Clinical Study

Cited by 4 publications

References 0 publications

From Basic Science to Clinical Practice: A Review of Current Periodontal/Mucogingival Regenerative Biomaterials

From Basic Science to Clinical Practice: A Review of Current Periodontal/Mucogingival Regenerative Biomaterials

Eficacia clínica del ácido hialurónico en el tratamiento del defecto intraóseo periodontal: una revisión sistemática y meta-análisis

Clinical efficacy of hyaluronic acid in the treatment of periodontal intrabony defect: a systematic review and meta-analysis

Contact Info

Product

Resources

About